The global market for Pharmacogenomics Technology (Theranostics & CDx) was valued at US$ 12590 million in the year 2024 and is projected to reach a revised size of US$ 32470 million by 2031, growing at a CAGR of 14.7% during the forecast period.

Pharmacogenomics Technology (Theranostics & CDx) Market

Pharmacogenomics Technology (Theranostics & CDx) manufacturers include Illumina, Roche and Agilent etc. The top 3 company holds a share of more than 50%. North America takes up the largest sales market, with a share of more than 40%, followed by Europe and China, with the share of about 30% and 10% respectively.

This report aims to provide a comprehensive presentation of the global market for Pharmacogenomics Technology (Theranostics & CDx), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenomics Technology (Theranostics & CDx).

The Pharmacogenomics Technology (Theranostics & CDx) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacogenomics Technology (Theranostics & CDx) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmacogenomics Technology (Theranostics & CDx) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmacogenomics Technology (Theranostics & CDx) Market Report

Report Metric	Details
Report Name	Pharmacogenomics Technology (Theranostics & CDx) Market
Accounted market size in year	US$ 12590 million
Forecasted market size in 2031	US$ 32470 million
CAGR	14.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Instrument Reagents and Consumables Others
Segment by Application	Tumor Diabetes Mental Diseases Cardiovascular Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Roche, Agilent, Abbott, Thermofisher, Qiagen, Guardant Health, MGI Tech Co., Ltd., Amoydx Biology, Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacogenomics Technology (Theranostics & CDx) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmacogenomics Technology (Theranostics & CDx) Market growing?

Ans: The Pharmacogenomics Technology (Theranostics & CDx) Market witnessing a CAGR of 14.7% during the forecast period 2025-2031.

What is the Pharmacogenomics Technology (Theranostics & CDx) Market size in 2031?

Ans: The Pharmacogenomics Technology (Theranostics & CDx) Market size in 2031 will be US$ 32470 million.

What is the Pharmacogenomics Technology (Theranostics & CDx) Market share by region?

Ans: North America takes up the largest sales market, with a share of more than 40%, followed by Europe and China, with the share of about 30% and 10% respectively.

Who are the main players in the Pharmacogenomics Technology (Theranostics & CDx) Market report?

Ans: The main players in the Pharmacogenomics Technology (Theranostics & CDx) Market are Illumina, Roche, Agilent, Abbott, Thermofisher, Qiagen, Guardant Health, MGI Tech Co., Ltd., Amoydx Biology, Genomics

What are the Application segmentation covered in the Pharmacogenomics Technology (Theranostics & CDx) Market report?

Ans: The Applications covered in the Pharmacogenomics Technology (Theranostics & CDx) Market report are Tumor, Diabetes, Mental Diseases, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Pharmacogenomics Technology (Theranostics & CDx) Market report?

Ans: The Types covered in the Pharmacogenomics Technology (Theranostics & CDx) Market report are Instrument, Reagents and Consumables, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Instrument

1.2.3 Reagents and Consumables

1.2.4 Others

1.3 Market by Application

1.3.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Mental Diseases

1.3.5 Cardiovascular Diseases

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Perspective (2020-2031)

2.2 Global Pharmacogenomics Technology (Theranostics & CDx) Growth Trends by Region

2.2.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmacogenomics Technology (Theranostics & CDx) Historic Market Size by Region (2020-2025)

2.2.3 Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Region (2026-2031)

2.3 Pharmacogenomics Technology (Theranostics & CDx) Market Dynamics

2.3.1 Pharmacogenomics Technology (Theranostics & CDx) Industry Trends

2.3.2 Pharmacogenomics Technology (Theranostics & CDx) Market Drivers

2.3.3 Pharmacogenomics Technology (Theranostics & CDx) Market Challenges

2.3.4 Pharmacogenomics Technology (Theranostics & CDx) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmacogenomics Technology (Theranostics & CDx) Players by Revenue

3.1.1 Global Top Pharmacogenomics Technology (Theranostics & CDx) Players by Revenue (2020-2025)

3.1.2 Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Players (2020-2025)

3.2 Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmacogenomics Technology (Theranostics & CDx) Revenue

3.4 Global Pharmacogenomics Technology (Theranostics & CDx) Market Concentration Ratio

3.4.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Technology (Theranostics & CDx) Revenue in 2024

3.5 Global Key Players of Pharmacogenomics Technology (Theranostics & CDx) Head office and Area Served

3.6 Global Key Players of Pharmacogenomics Technology (Theranostics & CDx), Product and Application

3.7 Global Key Players of Pharmacogenomics Technology (Theranostics & CDx), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacogenomics Technology (Theranostics & CDx) Breakdown Data by Type

4.1 Global Pharmacogenomics Technology (Theranostics & CDx) Historic Market Size by Type (2020-2025)

4.2 Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Type (2026-2031)

5 Pharmacogenomics Technology (Theranostics & CDx) Breakdown Data by Application

5.1 Global Pharmacogenomics Technology (Theranostics & CDx) Historic Market Size by Application (2020-2025)

5.2 Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size (2020-2031)

6.2 North America Pharmacogenomics Technology (Theranostics & CDx) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025)

6.4 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size (2020-2031)

7.2 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025)

7.4 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size (2020-2031)

8.2 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size (2020-2031)

9.2 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025)

9.4 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size (2020-2031)

10.2 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.1.4 Illumina Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.1.5 Illumina Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.2.4 Roche Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Agilent

11.3.1 Agilent Company Details

11.3.2 Agilent Business Overview

11.3.3 Agilent Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.3.4 Agilent Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.3.5 Agilent Recent Development

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.4.4 Abbott Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.4.5 Abbott Recent Development

11.5 Thermofisher

11.5.1 Thermofisher Company Details

11.5.2 Thermofisher Business Overview

11.5.3 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.5.4 Thermofisher Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.5.5 Thermofisher Recent Development

11.6 Qiagen

11.6.1 Qiagen Company Details

11.6.2 Qiagen Business Overview

11.6.3 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.6.4 Qiagen Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.6.5 Qiagen Recent Development

11.7 Guardant Health

11.7.1 Guardant Health Company Details

11.7.2 Guardant Health Business Overview

11.7.3 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.7.4 Guardant Health Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.7.5 Guardant Health Recent Development

11.8 MGI Tech Co., Ltd.

11.8.1 MGI Tech Co., Ltd. Company Details

11.8.2 MGI Tech Co., Ltd. Business Overview

11.8.3 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.8.4 MGI Tech Co., Ltd. Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.8.5 MGI Tech Co., Ltd. Recent Development

11.9 Amoydx Biology

11.9.1 Amoydx Biology Company Details

11.9.2 Amoydx Biology Business Overview

11.9.3 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.9.4 Amoydx Biology Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.9.5 Amoydx Biology Recent Development

11.10 Genomics

11.10.1 Genomics Company Details

11.10.2 Genomics Business Overview

11.10.3 Genomics Pharmacogenomics Technology (Theranostics & CDx) Introduction

11.10.4 Genomics Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

11.10.5 Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Instrument

Table 3. Key Players of Reagents and Consumables

Table 4. Key Players of Others

Table 5. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Region (2020-2025)

Table 9. Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Region (2026-2031)

Table 11. Pharmacogenomics Technology (Theranostics & CDx) Market Trends

Table 12. Pharmacogenomics Technology (Theranostics & CDx) Market Drivers

Table 13. Pharmacogenomics Technology (Theranostics & CDx) Market Challenges

Table 14. Pharmacogenomics Technology (Theranostics & CDx) Market Restraints

Table 15. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Players (2020-2025)

Table 17. Global Top Pharmacogenomics Technology (Theranostics & CDx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology (Theranostics & CDx) as of 2024)

Table 18. Ranking of Global Top Pharmacogenomics Technology (Theranostics & CDx) Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Pharmacogenomics Technology (Theranostics & CDx) Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Pharmacogenomics Technology (Theranostics & CDx), Headquarters and Area Served

Table 21. Global Key Players of Pharmacogenomics Technology (Theranostics & CDx), Product and Application

Table 22. Global Key Players of Pharmacogenomics Technology (Theranostics & CDx), Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Type (2020-2025)

Table 26. Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Type (2026-2031)

Table 28. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Application (2020-2025)

Table 30. Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Application (2026-2031)

Table 32. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2026-2031) & (US$ Million)

Table 47. Illumina Company Details

Table 48. Illumina Business Overview

Table 49. Illumina Pharmacogenomics Technology (Theranostics & CDx) Product

Table 50. Illumina Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 51. Illumina Recent Development

Table 52. Roche Company Details

Table 53. Roche Business Overview

Table 54. Roche Pharmacogenomics Technology (Theranostics & CDx) Product

Table 55. Roche Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 56. Roche Recent Development

Table 57. Agilent Company Details

Table 58. Agilent Business Overview

Table 59. Agilent Pharmacogenomics Technology (Theranostics & CDx) Product

Table 60. Agilent Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 61. Agilent Recent Development

Table 62. Abbott Company Details

Table 63. Abbott Business Overview

Table 64. Abbott Pharmacogenomics Technology (Theranostics & CDx) Product

Table 65. Abbott Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 66. Abbott Recent Development

Table 67. Thermofisher Company Details

Table 68. Thermofisher Business Overview

Table 69. Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Product

Table 70. Thermofisher Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 71. Thermofisher Recent Development

Table 72. Qiagen Company Details

Table 73. Qiagen Business Overview

Table 74. Qiagen Pharmacogenomics Technology (Theranostics & CDx) Product

Table 75. Qiagen Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 76. Qiagen Recent Development

Table 77. Guardant Health Company Details

Table 78. Guardant Health Business Overview

Table 79. Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Product

Table 80. Guardant Health Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 81. Guardant Health Recent Development

Table 82. MGI Tech Co., Ltd. Company Details

Table 83. MGI Tech Co., Ltd. Business Overview

Table 84. MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Product

Table 85. MGI Tech Co., Ltd. Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 86. MGI Tech Co., Ltd. Recent Development

Table 87. Amoydx Biology Company Details

Table 88. Amoydx Biology Business Overview

Table 89. Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Product

Table 90. Amoydx Biology Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 91. Amoydx Biology Recent Development

Table 92. Genomics Company Details

Table 93. Genomics Business Overview

Table 94. Genomics Pharmacogenomics Technology (Theranostics & CDx) Product

Table 95. Genomics Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025) & (US$ Million)

Table 96. Genomics Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Pharmacogenomics Technology (Theranostics & CDx) Picture

Figure 2. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Type: 2024 VS 2031

Figure 4. Instrument Features

Figure 5. Reagents and Consumables Features

Figure 6. Others Features

Figure 7. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Application: 2024 VS 2031

Figure 9. Tumor Case Studies

Figure 10. Diabetes Case Studies

Figure 11. Mental Diseases Case Studies

Figure 12. Cardiovascular Diseases Case Studies

Figure 13. Others Case Studies

Figure 14. Pharmacogenomics Technology (Theranostics & CDx) Report Years Considered

Figure 15. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Region: 2024 VS 2031

Figure 18. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Players in 2024

Figure 19. Global Top Pharmacogenomics Technology (Theranostics & CDx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology (Theranostics & CDx) as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Pharmacogenomics Technology (Theranostics & CDx) Revenue in 2024

Figure 21. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Pharmacogenomics Technology (Theranostics & CDx) Market Share by Country (2020-2031)

Figure 23. United States Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Share by Country (2020-2031)

Figure 27. Germany Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Share by Region (2020-2031)

Figure 35. China Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Share by Country (2020-2031)

Figure 43. Mexico Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Share by Country (2020-2031)

Figure 47. Turkey Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Illumina Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 52. Agilent Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 53. Abbott Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 54. Thermofisher Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 55. Qiagen Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 56. Guardant Health Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 57. MGI Tech Co., Ltd. Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 58. Amoydx Biology Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 59. Genomics Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene Sequencing Market Research Report 2024

Global Transcriptome Sequencing Market Research Report 2025

Global Predictive Genetic Testing and Genomics Market Research Report 2025

NSCLC Mutation Gene Analysis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmacogenomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmacogenetics Testing Market Research Report 2025

DNA Sequencing In Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genomic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Whole Genome Testing Services Market Research Report 2025

Genome Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Companion Diagnostics CDx Development Services Market Research Report 2024

Global Genomic Data Analysis and Interpretation Market Research Report 2024

Global Cellular and Gene Therapy CDMO Market Research Report 2025

Cell And Gene Therapy Clinical Trial Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chromosome Microarray Market Research Report 2025

Gene Therapy Medicinal Products GTMP Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanomaterials in Theranostics Market Insights Forecast to 2030

Global Embolotherapy Market Research Report 2025

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19T19555

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30T17927

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18L19449

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Metabolite Chemistry Reagents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-14103

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions